Nifty

:

24346.70

Sensex

:

80501.99

12.50 (0.05%)
259.75 (0.32%)

Login

Nifty
Sensex

:
:

24346.70
80501.99

12.50 (0.05%)
259.75 (0.32%)

Novartis India Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

N/A

BSE: 500672 | NSE: NOVARTIND

Watchlist

NSE BSE

868.20

06-Feb-2025

Open
High
Low
Previous Close

850.10
878.00
850.10
850.10

Volume
Traded Value (lacs)
52 Week High
52 Week Low

7814
67.65
1248.00
744.95

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,955.51
22.66
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,358.27
3.16%
2.59

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-9.14
-5.23
-5.72

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
40.93
19.53

PAT CAGR (%)

10 Years
5 Years
3 Years

0.74
53.24
-

P:E (Median)

8 Years
5 Years
3 Years

31.64
31.39
26.69

P:BV (Average)

8 Years
5 Years
3 Years

2.56
2.59
2.72

EV:EBITDA (Average)

8 Years
5 Years
3 Years

13.53
15.78
13.10

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 93.00 84.54 10.01% 87.10 78.76 10.59% 92.29 90.60 1.87% 81.17 76.13 6.62%
Expenses 67.42 64.77 4.09% 69.14 61.85 11.79% 68.32 73.28 -6.77% 69.96 66.81 4.71%
EBITDA 25.58 19.77 29.39% 17.96 16.91 6.21% 23.97 17.32 38.39% 11.21 9.32 20.28%
EBIDTM 27.51% 23.39% 20.62% 21.47% 25.97% 19.12% 13.81% 12.24%
Other Income 10.60 21.96 -51.73% 10.32 16.88 -38.86% 10.41 12.47 -16.52% 10.42 16.37 -36.35%
Interest 0.36 0.16 125.00% 0.14 0.71 -80.28% 0.15 0.46 -67.39% 0.16 0.30 -46.67%
Depreciation 0.53 0.26 103.85% 0.58 0.65 -10.77% 0.55 1.56 -64.74% 0.14 2.08 -93.27%
PBT 35.29 41.31 -14.57% 27.56 32.43 -15.02% 33.68 27.77 21.28% 21.33 23.31 -8.49%
Tax 9.84 14.74 -33.24% 7.15 8.75 -18.29% 7.94 7.51 5.73% 6.65 -1.71 -
PAT 25.45 26.57 -4.22% 20.41 23.68 -13.81% 25.74 20.26 27.05% 14.68 25.02 -41.33%
PATM 27.37% 31.43% 23.43% 30.07% 27.89% 22.36% 18.09% 32.86%
EPS 10.30 10.76 -4.28% 8.26 9.59 -13.87% 10.42 8.20 27.07% 5.94 10.13 -41.36%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 353.56 335.07 378.74 399.87 381.35 438.25 490.68 563.89 656.22 689.77 873.38 Net Sales Growth 7.13% -11.53% -5.28% 4.86% -12.98% -10.69% -12.98% -14.07% -4.86% -21.02% Cost Of Goods Sold 210.41 199.84 201.69 178.14 146.61 182.32 198.65 245.51 306.10 286.31 349.02 Gross Profit 143.15 135.23 177.05 221.73 234.74 255.93 292.03 318.38 350.12 403.46 524.36 GP Margin 40.49% 40.36% 46.75% 55.45% 61.56% 58.40% 59.52% 56.46% 53.35% 58.49% 60.04% Total Expenditure 274.84 269.81 313.66 373.12 355.66 426.51 478.54 572.12 631.70 658.95 881.18 Power & Fuel Cost - 0.18 0.35 0.53 0.53 1.27 1.79 2.56 1.77 4.43 4.87 % Of Sales - 0.05% 0.09% 0.13% 0.14% 0.29% 0.36% 0.45% 0.27% 0.64% 0.56% Employee Cost - 22.96 35.64 101.89 108.51 113.87 117.11 144.53 139.30 156.66 200.03 % Of Sales - 6.85% 9.41% 25.48% 28.45% 25.98% 23.87% 25.63% 21.23% 22.71% 22.90% Manufacturing Exp. - 7.54 15.51 34.49 36.52 39.23 42.21 42.07 49.03 62.35 98.47 % Of Sales - 2.25% 4.10% 8.63% 9.58% 8.95% 8.60% 7.46% 7.47% 9.04% 11.27% General & Admin Exp. - 15.37 17.09 18.61 12.95 23.40 43.28 45.74 45.74 47.65 64.48 % Of Sales - 4.59% 4.51% 4.65% 3.40% 5.34% 8.82% 8.11% 6.97% 6.91% 7.38% Selling & Distn. Exp. - 15.87 27.98 35.66 39.77 53.99 60.29 72.48 75.83 70.74 131.14 % Of Sales - 4.74% 7.39% 8.92% 10.43% 12.32% 12.29% 12.85% 11.56% 10.26% 15.02% Miscellaneous Exp. - 8.05 15.40 3.80 10.77 12.43 15.21 19.23 13.93 30.81 131.14 % Of Sales - 2.40% 4.07% 0.95% 2.82% 2.84% 3.10% 3.41% 2.12% 4.47% 3.80% EBITDA 78.72 65.26 65.08 26.75 25.69 11.74 12.14 -8.23 24.52 30.82 -7.80 EBITDA Margin 22.26% 19.48% 17.18% 6.69% 6.74% 2.68% 2.47% -1.46% 3.74% 4.47% -0.89% Other Income 41.75 61.68 58.11 33.55 34.19 36.43 78.40 173.81 71.52 244.55 111.58 Interest 0.81 1.49 1.75 4.83 7.68 6.39 1.59 5.53 0.72 0.21 0.21 Depreciation 1.80 2.61 6.06 9.65 12.16 13.14 3.18 2.53 3.59 3.49 4.01 PBT 117.86 122.84 115.38 45.82 40.04 28.64 85.77 157.52 91.73 271.67 99.56 Tax 31.58 37.65 12.02 -0.10 19.14 18.56 34.00 79.16 34.51 73.38 14.12 Tax Rate 26.79% 30.65% 10.42% 2.62% 47.80% 64.80% 39.64% 50.25% 37.62% 27.01% 15.15% PAT 86.28 85.19 103.36 -3.72 20.90 10.08 51.77 78.36 57.22 198.29 79.11 PAT before Minority Interest 86.28 85.19 103.36 -3.72 20.90 10.08 51.77 78.36 57.22 198.29 79.11 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 24.40% 25.42% 27.29% -0.93% 5.48% 2.30% 10.55% 13.90% 8.72% 28.75% 9.06% PAT Growth -9.68% -17.58% - - 107.34% -80.53% -33.93% 36.95% -71.14% 150.65% EPS 34.93 34.49 41.85 -1.51 8.46 4.08 20.96 31.72 23.17 80.28 32.03

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 744.82 775.66 691.70 711.19 720.73 759.19 733.64 919.64 1,193.58 1,001.99 Share Capital 12.34 12.34 12.34 12.34 12.34 12.34 12.34 14.07 15.98 15.98 Total Reserves 732.48 763.36 681.58 701.80 711.68 751.10 727.48 913.00 1,184.54 986.01 Non-Current Liabilities 716.25 1,007.77 984.00 1,130.65 99.38 891.47 897.75 827.53 26.47 696.64 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 726.33 998.39 991.58 1,109.57 65.93 909.70 916.30 844.46 45.85 714.94 Current Liabilities 399.83 268.26 334.47 357.26 416.93 367.22 481.74 323.21 204.49 361.82 Trade Payables 61.59 59.67 72.20 55.20 72.60 91.40 106.11 73.22 69.66 94.52 Other Current Liabilities 33.54 38.03 45.34 69.64 132.99 67.62 184.52 63.26 88.94 52.24 Short Term Borrowings 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 304.68 170.56 216.93 232.42 211.34 208.20 191.11 186.73 45.89 215.06 Total Liabilities 1,860.90 2,051.69 2,010.17 2,199.10 1,237.04 2,017.88 2,113.13 2,070.38 1,424.54 2,060.45 Net Block 6.94 19.25 23.65 63.91 76.28 14.98 4.60 5.71 6.48 8.50 Gross Block 28.36 38.92 40.71 74.81 85.08 23.93 12.09 10.82 9.87 26.08 Accumulated Depreciation 21.42 19.67 17.06 10.90 8.80 8.95 7.49 5.11 3.39 17.58 Non Current Assets 919.01 1,265.59 1,183.39 1,276.75 239.77 1,029.20 1,008.86 958.91 160.85 845.95 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.45 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 Long Term Loans & Adv. 903.63 1,240.75 1,148.65 1,186.01 137.84 989.61 979.98 935.98 153.29 837.20 Other Non Current Assets 8.44 5.59 11.09 26.83 25.65 24.61 24.28 17.21 0.63 0.24 Current Assets 941.89 786.06 825.87 922.35 997.27 988.68 1,104.27 1,111.47 1,263.69 1,214.50 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 44.86 54.72 57.07 47.95 58.68 60.51 56.56 87.52 72.40 99.94 Sundry Debtors 41.47 36.16 44.56 38.73 37.60 45.59 43.91 40.83 50.17 82.90 Cash & Bank 596.08 555.94 517.63 498.88 581.91 612.02 775.08 815.72 1,125.55 838.55 Other Current Assets 259.48 15.95 15.49 46.30 319.08 270.56 228.72 167.40 15.57 193.11 Short Term Loans & Adv. 257.44 123.29 191.12 290.49 259.99 236.02 202.29 146.86 9.99 190.34 Net Current Assets 542.06 517.80 491.40 565.09 580.34 621.46 622.53 788.26 1,059.20 852.68 Total Assets 1,860.90 2,051.65 2,009.26 2,199.10 1,237.04 2,017.88 2,113.13 2,070.38 1,424.54 2,060.45

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 113.40 44.80 38.67 -69.21 -23.14 -194.28 160.99 -40.83 56.59 -59.59 PBT 122.84 115.38 -3.82 40.04 28.64 85.77 157.52 91.73 111.37 99.56 Adjustment -56.75 -48.92 -5.64 -4.98 -11.80 -72.66 -55.87 -55.95 -67.04 -84.63 Changes in Working Capital 9.04 -24.00 66.72 -69.08 -1.85 -161.76 117.30 -32.45 91.70 -31.81 Cash after chg. in Working capital 75.13 42.46 57.26 -34.02 14.99 -148.65 218.95 3.33 136.03 -16.88 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 38.27 2.34 -18.59 -35.19 -38.13 -45.63 -57.96 -44.16 -79.44 -36.38 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -6.33 Cash From Investing Activity 33.13 -153.25 87.04 95.16 55.91 274.23 68.70 423.64 -630.47 718.94 Net Fixed Assets 10.56 1.79 34.10 10.27 -61.15 -11.84 -1.26 -0.51 15.76 -2.10 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 Others 22.57 -155.04 52.94 84.89 117.06 286.07 69.96 424.15 -646.24 721.02 Cash from Financing Activity -120.99 -30.48 -35.63 -36.80 -41.41 -29.82 -267.65 -331.80 -38.57 -37.67 Net Cash Inflow / Outflow 25.54 -138.93 90.08 -10.85 -8.64 50.13 -37.96 51.01 -612.45 621.68 Opening Cash & Equivalents 19.42 158.35 68.27 79.12 87.76 37.63 75.59 24.58 637.03 15.35 Closing Cash & Equivalent 44.96 19.42 158.35 68.27 79.12 87.76 37.63 75.59 24.58 637.03

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 301.79 314.30 281.17 289.36 293.36 309.34 299.76 329.45 375.63 313.51 ROA 4.35% 5.09% -0.18% 1.22% 0.62% 2.51% 3.75% 3.27% 11.38% 3.89% ROE 11.21% 14.07% -0.53% 2.91% 1.36% 6.89% 9.40% 5.38% 18.01% 8.06% ROCE 16.35% 15.96% 0.14% 6.67% 4.73% 11.70% 19.72% 8.75% 24.77% 9.52% Fixed Asset Turnover 10.90 10.39 8.43 5.68 9.77 32.72 59.76 63.43 38.38 34.93 Receivable days 38.62 35.62 31.23 30.70 28.50 27.72 22.59 25.31 35.20 33.46 Inventory Days 49.54 49.34 39.38 42.89 40.83 36.25 38.41 44.47 45.59 42.48 Payable days 110.74 119.32 130.52 159.09 74.34 84.28 68.27 44.09 50.69 46.89 Cash Conversion Cycle -22.58 -34.36 -59.90 -85.49 -5.01 -20.31 -7.27 25.70 30.10 29.04 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 83.44 66.93 0.21 6.21 5.48 54.94 29.48 128.40 1294.67 444.95

Top Investors:

investor education and protection fund (iepf)

Annual Reports:

News Update:

Novartis - Quarterly Results
28th Jan 2025, 13:18 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback